Clinical Trial Update: Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial update on high-dose Evomela injection for conditioning in autologous stem cell transplantation for multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• EVOMELA (melphalan hydrochloride)

Snippet

Sponsor: Acrotech Biopharma Inc. | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED